-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
May 21, 2015 - Affiliation Section Comment Response
do not target this population (e.g., excluded studies…”
In defining
-
integrationacademy.ahrq.gov/sites/default/files/2025-06/Innovations%20in%20Behavioral%20Health%20Integration_Transcript.docx
January 01, 2025 - Anna Ratzliff (she/her): So in this particular case, we really did conceptualize that as what we were defining
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Studies better
defining the potential long-term risks (breast cancer and cardiovascular risks) need
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication
April 26, 2022
Recommendations made by the USPSTF are independent of the U.S. government…
-
digital.ahrq.gov/sites/default/files/docs/page/findings-and-lessons-from-the-improving-quality-through-clinician-use-of-health-it.pdf
January 28, 2014 - Findings and Lessons From the Improving Quality Through Clinician Use of Health IT Grant Initiative
AHRQ Health Information Technology Ambulatory Safety and Quality | IQHITi
AHRQ Health Information Technology
Ambulatory Safety and Quality
Findings and Lessons
From the Improving Quality
Through Clinician Use
of…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
September 01, 2008 - new disposition of comments insulin analogues -- jda revs.xls
Comment, by Section Response
Executive Summary
Comment: A statement under Gaps in Evidence and Future Direction…
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/quality-patient-safety/patientsafetyculture/2018mosopsdatabasereport-part1.pdf
April 01, 2018 - Medical Office Survey on Patient Safety Culture: 2018 User Database Report Part I
PATIENT
SAFETY
MEDICAL OFFICE
SURVEY
ON PATIENT
SAFETY CULTURE
2018 USER DATABASE REPORT
The authors of this report are responsible for its content. Statements in the report
should not be construed as endorsement by the Agency…
-
hcup-us.ahrq.gov/reports/factsandfigures/2009/pdfs/FF_2009_section5.pdf
January 01, 2009 - HCUP Facts and Figures: Statistics on Hospital-Based Care in the United States, 2009 53
SECTION 5 WOMEN’S HEALTH
EXHIBIT 5.1 Overview of Female and Male Hospital Stays .............................................................. 56
EXHIBIT 5.2 Common Conditions During Hospital Stays for Females ...…
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017072-lobach-final-report-2011.pdf
January 01, 2011 - Improving Quality through Decision Support for Evidence-Based Pharmacotherapy
Grant Final Report
Grant ID: R18 HS017072
Improving Quality through Decision Support for
Evidence-Based Pharmacotherapy
Inclusive project dates: 09/01/07 - 08/31/11
Principal Investigator:
David F. Lobach, MD, PhD, …
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Cross-Cutting Interventions and Programs
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
Contract No. HH…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
January 01, 2015 - Research White Paper
Comparison of Effects as Evidence Evolves From
Single Trials to High-Quality Bodies of Evidence
Research White Paper
Comparison of Effects as Evidence Evolves From
Single Trials to High-Quality Bodies of Evidence
Prepared for:
Agency for Healthc…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/carbapenem-resistant-1.pdf
March 01, 2020 - Chapter-6 - Carbapenem-Resistant-Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae 6-1
6. Carbapenem-Resistant Enterobacteriaceae
Authors: Elizabeth Gall, M.H.S., and Anna Long, M.P.H.
Reviewer: Caroline Logan, Ph.D., and Pranita Tamma, M.D.
Introduction
Background
Carbapenem-resistant Enterobacteria…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/reducing-adverse-drug-1.pdf
March 01, 2020 - Making Healthcare Safer Practices: 9. Reducing Adverse Drug Events in Older Adults
Reducing Adverse Drug Events in Older Adults 9-1
9. Reducing Adverse Drug Events in Older Adults
Authors: Tara R. Earl, Ph.D., M.S.W., Nicole D. Katapodis, M.P.H., and Stephanie R. Schneiderman, M.P.P.
Reviewers: Scott Winiecki, M.D…
-
www.ahrq.gov/sites/default/files/2024-01/bailey-kilbridge-report.pdf
January 01, 2024 - Final Progress Report: Surveillance for Adverse Drug Events in Ambulatory Pediatrics
1. Title: Surveillance for Adverse Drug Events in Ambulatory Pediatrics
Principal Investigator(s): Thomas C. Bailey (07/15/09—02/28/11)
Peter M. Kilbridge (09/01/07—07/14/09)
Team Members: Laura A. Noirot
Richard M. Reichley
…
-
www.ahrq.gov/sites/default/files/2024-10/kennerly-ballard-report.pdf
January 01, 2024 - Final Progress Report: Adverse Event-Directed Analysis in Ambulatory Primary Care
Adverse Event-Directed Analysis in Ambulatory Primary
Care Final Report
September 30, 2009
Principal Investigator: Donald Kennerly, MD, PhD
Team Members:
David Ballard, MD, MSPH, PhD, Co-Investigator
S. Quay Mercer, BS, MT (ASCP…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-081-fullreport.pdf
April 01, 2019 - CHIPRA 81: Pediatric Global Health-7 Measure Report
1
Pediatric Global Health-7 Measure
Section 1. Basic Measure Information
1.A. Measure Name
Pediatric Global Health-7 (PGH-7) Measure
1.B. Measure Number
0081
1.C. Measure Description
Please provide a non-technical description of the measure that convey…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-cholesterol-other-lipid-abnormalities-screening-1996
January 01, 1996 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996
January 01, 1996
Recommendations made by the USPSTF are in…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
December 15, 2010 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Falls Prevention in Older Adults: Counseling and Preventive Medication
December 15, 2010
Recommendations made by the USPSTF are independent o…
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-teamwork-leadership.pdf
April 30, 2025 - AHRQ-Funded Patient Safety Project Highlights: Improving Healthcare Safety by Enhancing Teamwork and Leadership
AHRQ-Funded Patient Safety
Project Highlights
Improving Healthcare Safety by
Enhancing Teamwork and Leadership
Overview
According to the Joint Commission, in 2022, failures in communication, teamwork, a…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/CXDusYW7s2xdypXMpnW9sw
June 20, 2023 - Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force
Anxiety Screening
Evidence Report and Systematic Review
for the US Preventive Services Task Force
Elizabeth A. O’Connor, PhD; Michelle L. Henninger, PhD; Leslie A. Perdue, MPH; Erin L. Coppola, MPH;
Rachel G. Thomas, MP…